(B)(4). SAME PATIENT AS 2134265-2010-04220. IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY TREATMENT PROCEDURE, THE PATIENT EXPERIENCED ANGINA WITH ELEVATED TROPONINS AND REQUIRED A TARGET VESSEL REINTERVENTION. LESION 1 WAS LOCATED IN THE 1ST OBTUSE MARGINAL (OM) WITH 90% STENOSIS AND WAS 5.0 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.5 MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION AND SUCCESSFULLY IMPLANTING A 3.00MM X 12MM TAXUS LIBERTE STENT. POST-DILATATION WAS PERFORMED WITH 0% RESIDUAL STENOSIS. LESION 2 WAS A BIFURCATED LESION LOCATED IN THE PROXIMAL CIRCUMFLEX WITH 95% STENOSIS AND WAS 12MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.5 MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION SUCCESSFULLY IMPLANTING A 3.50MM X 16MM TAXUS LIBERTE STENT. POST-DILATATION WAS PERFORMED WITH 0% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASPIRIN AND PRASUGREL. AT 54 DAYS POST-INDEX PROCEDURE, THE PATIENT DEVELOPED UNSTABLE ANGINA WITH ELEVATED TROPONINS. CORONARY ANGIOGRAPHY REVEALED A STENT THROMBOSIS AND IN-STENT RESTENOSIS WITH TOTAL OCCLUSION. IT WAS NOTED THAT THE STUDY STENT WAS SOMEWHAT UNEXPANDED. THE PATIENT UNDERWENT A TARGET VESSEL RE-INTERVENTION OF THE 1ST (OM). POST-PROCEDURE RESIDUAL STENOSIS WAS 0% AND TIMI FLOW WAS 3. THE PATIENT WAS DISCHARGED 4 DAYS LATER.
